Literature DB >> 27252447

Anti-inflammatory treatment of acute coronary syndromes: the need for precision medicine.

Filippo Crea1, Giovanna Liuzzo2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27252447     DOI： 10.1093/eurheartj/ehw207

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.

Authors:  Arash Gholoobi; Vahid Reza Askari; Hossein Naghedinia; Mostafa Ahmadi; Vida Vakili; Vafa Baradaran Rahimi
Journal:  Inflammopharmacology       Date:  2021-08-21       Impact factor: 4.473

2.  C-reactive protein during and after myocardial infarction in relation to cardiac injury and left ventricular function at follow-up.

Authors:  Maarten Vanhaverbeke; Denise Veltman; Nele Pattyn; Nico De Crem; Hilde Gillijns; Véronique Cornelissen; Stefan Janssens; Peter R Sinnaeve
Journal:  Clin Cardiol       Date:  2018-09-20       Impact factor: 2.882

Review 3.  Cardiovascular events, diabetes and guidelines: the virtue of simplicity.

Authors:  Ricardo J Esper; Roberto A Nordaby
Journal:  Cardiovasc Diabetol       Date:  2019-03-28       Impact factor: 9.951

4.  Association Between Endophthalmitis and the Incidence of Acute Coronary Syndrome in Patients With Ankylosing Spondylitis: A Nationwide, Population-Based Cohort Study.

Authors:  Ting-Yi Lin; Yi-Fen Lai; Wu-Chien Chien; Yi-Hao Chen; Chien-An Sun; Chi-Hsiang Chung; Jiann-Torng Chen; Ching-Long Chen
Journal:  Front Immunol       Date:  2022-03-25       Impact factor: 7.561

5.  Potential role for pentoxifylline as an anti-inflammatory drug for patients with acute coronary syndrome.

Authors:  Daniel Miron Brie; Cristian Mornos; Diduta Alina Brie; Constantin Tudor Luca; Lucian Petrescu; Madalina Boruga
Journal:  Exp Ther Med       Date:  2022-04-08       Impact factor: 2.447

6.  IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.

Authors:  Hilde L Orrem; Per H Nilsson; Søren E Pischke; Ola Kleveland; Arne Yndestad; Karin Ekholt; Jan K Damås; Terje Espevik; Bjørn Bendz; Bente Halvorsen; Ida Gregersen; Rune Wiseth; Geir Ø Andersen; Thor Ueland; Lars Gullestad; Pål Aukrust; Andreas Barratt-Due; Tom E Mollnes
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

7.  Comparison of Efficacy between Clopidogrel and Ticagrelor in Patients with Acute Coronary Syndrome after Interventional Treatment and Their Effects on IL-6.

Authors:  Bin Yang; Chunyan Zheng; Haichu Yu; Rui Zhang; Shan Li; Min Len; Shanglang Cai
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.